Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Narrow Spectrum Kinase Inhibitors Demonstrate Promise for the Treatment of Dry Eye Disease and Other Ocular Inflammatory Disorders
Suzanne Hagan, Matthew C. T. Fyfe, Boatemaa Ofori‐Frimpong, et al.
Investigative Ophthalmology & Visual Science (2018) Vol. 59, Iss. 3, pp. 1443-1443
Open Access | Times Cited: 13

Showing 13 citing articles:

Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
Mihir Shah, Sara Cabrera-Ghayouri, Lori‐Ann Christie, et al.
Pharmaceutical Research (2019) Vol. 36, Iss. 4
Open Access | Times Cited: 46
Pathophysiology of dry eye disease and novel therapeutic targets
Elisabeth M. Messmer
Experimental Eye Research (2022) Vol. 217, pp. 108944-108944
Closed Access | Times Cited: 22
Recent advances in drug treatments for dry eye disease
Giulia Coco, G. Ambrosini, Silvia Poletti, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 18, pp. 2059-2079
Closed Access | Times Cited: 11
Emerging therapies for dry eye disease
Lauren Mason, Saad Jafri, Isabelle Dortonne, et al.
Expert Opinion on Emerging Drugs (2021) Vol. 26, Iss. 4, pp. 401-413
Closed Access | Times Cited: 19
Current and Future Pharmacological Therapies for the Management of Dry Eye
Preeya K. Gupta, Penny A. Asbell, John D. Sheppard
Eye & Contact Lens Science & Clinical Practice (2019) Vol. 46, Iss. 2, pp. S64-S69
Closed Access | Times Cited: 18
<p>A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease</p>
Mike Taylor, George W Ousler, Gail Torkildsen, et al.
Clinical ophthalmology (2019) Vol. Volume 13, pp. 261-275
Open Access | Times Cited: 13
Selecting Appropriate Reference Genes for Quantitative Real-Time Polymerase Chain Reaction Studies in Isolated and Cultured Ocular Surface Epithelia
Sara I. Van Acker, Zoë P. Van Acker, Michel Haagdorens, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Use of Laplacian Heat Diffusion Algorithm to Infer Novel Genes With Functions Related to Uveitis
Shiheng Lu, Ke Zhao, Xuefei Wang, et al.
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 7
In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal Models
Yi-Yong Baek, Bokyung Sung, Jun‐Sub Choi, et al.
Translational Vision Science & Technology (2021) Vol. 10, Iss. 11, pp. 14-14
Open Access | Times Cited: 5
Pharmacodynamic Evaluation: Ocular Pharmacology
Najam A. Sharif
Springer eBooks (2019), pp. 1-46
Closed Access | Times Cited: 2
Effects of Buddlejae Flos Granules on Inflammatory Factors TGF-β1, NF-κB, IL-10 and IL-12 in Lacrimal Gland Cells of Castrated Male Rabbits
Peng-Fei Jiang, Jun Peng, Tan Han-yu, et al.
Digital Chinese Medicine (2019) Vol. 2, Iss. 2, pp. 97-104
Open Access
Pharmacodynamic Evaluation: Ocular Pharmacology
Najam A. Sharif
Springer eBooks (2020), pp. 163-208
Closed Access
Quantitation of Pax-6 protein in ocular impression cytology samples using an electrochemiluminescence immunoassay
Phillip G. Zaworski, Rachel Schwartz, Jeffrey A. Burr, et al.
Analytical Biochemistry (2022) Vol. 656, pp. 114876-114876
Open Access
Page 1

Scroll to top